Earnings Sentiment

Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.

Please consider a small donation if you think this website provides you with relevant information  

    

Sentiment Distribution

   

Earnings Call Transcript Word Cloud

     

Bullish Statements during Earnings call

Statement
Conversely, over the last 12 months, future exams scheduled were negative year-over-year, but the rate has steadily improved in the most recent months covered by the report, which we believe may be a good gauge for consumer optimism
So, we're seeing good doctor engagement and that's on both the GP side and the ortho side
So I'd look at this as a positive statement that we're ready to engage and invest with our partners that share our vision
And in particular, with some of the improvements that we're seeing with higher utilization in Poland, as that plant continues to ramp up, will -- we see improvements in gross margin that way
And the team segment, which represents the largest portion of the 21 million annual orthodontic case starts 182,000 teens and kids started treatment with Invisalign Clear Aligners during the first quarter, increasing both sequentially and year-over-year, which is encouraging as we head into the important summer season for teens and kids
Overall, remain confident in our large underpenetrated market opportunity globally
In closing, we're pleased with our first quarter results that reflected an environment of continued stability for our doctor customers
We're confident in our durable competitive advantage as we continue to transform the orthodontic industry, bringing digital dentistry and clear line of treatment to more doctors and the patients they serve, driven by our strategic initiatives of international expansion, orthodontist utilization, general dentist treatment and patient demand and conversion
We are confident in our ability to address the massive opportunity for digital orthodontics and restorative dentistry, with our execution centered on our strategic initiatives
It's a good relationship and has a good trajectory from a growth standpoint
The orthodontic piece is a good signal to
Q1 non-case revenues were up sequentially and year-over-year, reflecting continued growth from DSP, Vivera Retainers in commerce sales, which include everything from a liner cases to whitening and cleaning products
DSP has been very successful and enabling doctors to purchase aligners on a subscription basis, giving them flexibility to treat simple touch up cases, or offer their patients a superior flexible and convenient retention solution
What's really great is a very synergistic effect, too, in the sense of how they execute on their clinicals throughout their organization from an efficiency standpoint, how to teach our doctors to use our product to enhance what their capability is in the digital dentistry side
Systems and Services gross margin for the first quarter was 61.6%, up 2.8 points sequentially primarily from increased manufacturing efficiencies
Through their network of doctors and systematic approach to clinical education and practice management, DSOs are uniquely positioned to drive adoption of new technologies and tools that increase practice efficiency and profitability and deliver a better patient experience
The sequential increase in first quarter revenues of 943 million reflects stability across all regions for Clear Aligner business and favorable average selling price for the Clear Aligner and Systems and Services segments
So what we really like about with Heartland, and we have a good relationship with other DSOs with Heartland is a really good focus from a digital standpoint and good execution around how they want to move that to the marketplace to their doctors
Overall, I'm please report better than expected first quarter revenues and earnings
For EMEA, Q1 Clear Aligner volumes include strong adoption of Invisalign moderate across the region in both the adult and team segments
For APAC, Q1 Clear Aligner volumes reflect improvement in China and continued growth in markets like Japan, Korea and India with positive year-over-year growth, including teams
And so, I feel good about it because I think it matched our customer expectations with what we need from a business standpoint
We are pleased with the initial adoption of the Invisalign comprehensive -- and anticipate that its impact will be more meaningful, providing doctors the flexibility they desire and allowing us to recognize more revenue upfront with deferred revenue being recognized over a shorter period of time compared to our traditional Invisalign comprehensive product
For Q1, total Clear Aligner cases for teenagers were up sequentially and year-over-year, reflecting improving trends across the regions
2Q is at least being guided above the street, which I say encouraging
So what we feel good about is that we're seeing decent stability in those numbers
We saw our DSOs in the United States execute really well around adults, which shows you that if you have the right kind of focus, you can still have a good patient yield on the adult side, if you're working that piece
These benefits, along with positive compliance experience, may also contribute to continued momentum for Invisalign First
It's great revenue for us
It was really well received by the marketplace and very from a GP standpoint and ortho standpoint too
       

Bearish Statements during earnings call

Statement
Processes and services in Q1 revenues of 153.3 million were down 9.7% sequentially, and 6.2% year-over-year
As expected Q1 systems and services revenues decreased sequentially consistent with seasonal capital equipment cycles compared to Q4
Clear Aligner gross margin for the first quarter was down 3.1 points year-over-year, primarily to lower ASPs, increased manufacturing spend as we continue to ramp up operations at our new manufacturing facility in Poland and a higher mix of additional aligner volume
On a year-over-year basis, Q1 Clear Aligner revenues were down 2.5%, primarily due to lower volumes, lower ASPs, including unfavorable foreign exchange, partially offset by higher non-case revenues
Don't look at the fourth quarter and first quarter as any kind of a signal to say that we're losing momentum in that business
And as they're growing, then I'm assuming the 4% year-over-year case volume contraction you reported this year in the first quarter looks a little worse than it actually would have been if DSP wasn't out there
Systems and Services gross margin for the first quarter was down 1.8 points year-over-year due to lower volumes, partially offset by higher services revenues and ASPs
I think the overall piece here is you have to look at a continued challenge from an adult standpoint, when you look at our numbers across the globe
Total revenues for the first quarter were $943.1 million, up 4.6% from the prior quarter and down 3.1% from the corresponding quarter a year ago
On a year-over-year basis, System and Services revenues were unfavorably impacted by foreign exchange of approximately $5.8 million or approximately 3.6%
I mean if anything has been consistent, we have seen the pressure on adults during this whole downturn
Investments in go-to-market teams and technology as well as unfavorable impact from foreign exchange by approximately two points
The year-over-year decrease in operating margin is primarily attributed to lower gross margin
Q1 23 systems and services revenue of $153.3 million were down 9.7% sequentially primarily due to the seasonally lower scanner volume, partially offset by higher services revenues from our larger base of scanners sold, higher revenues from our CPO and leasing rental programs and favorable ASPs, down 6.2% year-over-year primarily for the reasons just stated
However, the macroeconomic environment remains uncertain
The Q1 total Clear Aligner of revenues of 789.8 million was up sequentially and down year-over-year
For Q1 system and services revenues were sequentially lower primarily in the Americas and APAC regions, offset somewhat by an increase in EMEA
Our overall days sales outstanding was $83, down approximately two days sequentially and down approximately four days as compared to Q1 last year
The cases were down quarter-over-quarter
Operating margin for the first quarter was 18.5%, up 0.2 points sequentially and down 5.5 points year-over-year
   

Please consider a small donation if you think this website provides you with relevant information